Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China flag China · Delayed Price · Currency is CNY
6.76
-0.15 (-2.17%)
Nov 13, 2026, 3:00 PM CST

SHA:600351 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
914.45820.51578.59617.64668.5477.05
Trading Asset Securities
3.44-----
Cash & Short-Term Investments
917.89820.51578.59617.64668.5477.05
Cash Growth
40.27%41.81%-6.32%-7.61%40.13%36.10%
Accounts Receivable
281.75361.99444.15601.32716.18667.79
Other Receivables
12.726.7943.9535.1470.5991.72
Receivables
294.45388.78488.1636.45786.77759.52
Inventory
286.16315.73413.05442.13449.14521.01
Prepaid Expenses
-0.110.0100.03-
Other Current Assets
49.0152.9479.5656.8149.939.51
Total Current Assets
1,5481,5781,5591,7531,9541,797
Property, Plant & Equipment
991.981,0541,2031,3081,3771,454
Long-Term Investments
288.87317.47372.61377.72346.43314.68
Goodwill
26.2726.2726.2726.2726.2774.57
Other Intangible Assets
144.48136.57146.99154.96155.6157.39
Long-Term Deferred Tax Assets
26.7723.8741.8931.234.6128.46
Long-Term Deferred Charges
88.8789.05138.28155.8179.27146.35
Other Long-Term Assets
59.4360.755.4646.6957.73104.03
Total Assets
3,1743,2863,5443,8544,1314,077

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
137.97106.39153.34191.7166.94120.66
Accrued Expenses
54.85111.396.17123.09130.69111.71
Short-Term Debt
--90.07200.22410.26502.37
Current Portion of Long-Term Debt
-0.02-221.011.01
Current Portion of Leases
1.860.563.573.413.283.85
Current Income Taxes Payable
30.7311.494.076.3212.245.99
Current Unearned Revenue
57.5668.7780.4467.32108.4890.2
Other Current Liabilities
159.1286.71154.35191.4187.77169.62
Total Current Liabilities
442.09385.24582.02785.461,0411,005
Long-Term Debt
-35--223
Long-Term Leases
1.940.572.063.375.18.52
Long-Term Unearned Revenue
29.3437.1337.2443.5347.9946.1
Long-Term Deferred Tax Liabilities
3.173.1799.269.9511.36
Other Long-Term Liabilities
--18.7218.7218.7218.72
Total Liabilities
476.54461.11649.02860.331,1241,113

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
692692720770770770
Additional Paid-In Capital
550.45550.45703.76955.1955.32955.32
Retained Earnings
1,5471,6711,5611,4261,2651,222
Treasury Stock
-5--66.06-150.45--
Comprehensive Income & Other
-27.5-28.86-25.7-24.41-20.01-20.05
Total Common Equity
2,7572,8842,8932,9762,9702,927
Minority Interest
-58.96-59.112.2817.1236.5636.62
Shareholders' Equity
2,6982,8252,8952,9933,0072,964
Total Liabilities & Equity
3,1743,2863,5443,8544,1314,077

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
3.836.1595.7209441.65538.74
Net Cash (Debt)
914.09784.36482.9408.64226.85-61.69
Net Cash Growth
65.31%62.43%18.17%80.14%--
Net Cash Per Share
1.321.120.670.540.29-0.08
Filing Date Shares Outstanding
691.79692700720770770
Total Common Shares Outstanding
691.79692709.5748.7770770
Working Capital
1,1051,193977.3967.58913.67791.68
Book Value Per Share
3.984.174.083.983.863.80
Tangible Book Value
2,5862,7212,7192,7952,7882,695
Tangible Book Value Per Share
3.743.933.833.733.623.50
Buildings
-1,5371,6311,6131,5971,545
Machinery
-1,3691,3861,3601,3421,340
Construction In Progress
-3.9315.4957.4125.8326.48